According to current guidelines [29] , supplementation with calcium (1,000-1,200 mg/day) and vitamin D (400-800 IU/day), though not evidence-based, should be considered in all patients with cholestatic liver disease. Alendronate or other bisphosphonates are recommended at a T score < −2.5 (DEXA) or following pathological fracture.